Learn More
Medchemexpress LLC 5-(3-chloro-4-cyclohexylphenyl)-1-(3-methoxyphenyl)-1H-pyrazole-3-carboxylic acid | 1393814-38-4 | 99.7% | 410.89 | C23H23ClN2O3 | 100 MG

Supplier: Medchemexpress LLC HY107615100MG
TC LPA5 4 is a selective, non-lipid antagonist of the lysophosphatidic acid receptor LPA5 (GPR92). It inhibits LPA-induced platelet aggregation and reduces proliferation and migration in certain cancer cell lines, with reported IC50 ≈ 0.8 μM in LPA5-RH7777 cells. Supplied as a high-purity research compound (C23H23ClN2O3, MW 410.89).
- Selective LPA5 receptor antagonist suitable for receptor pharmacology studies.
- Inhibits LPA-induced platelet aggregation with low micromolar potency.
- High purity for reliable biological assay results.
- Characterized by molecular formula C23H23ClN2O3 and MW 410.89.
- Available in milligram-scale packs for preclinical research.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.